These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15510390)

  • 1. Expanding role of conformulations in the treatment of HIV infection: impact of fixed-dose combinations.
    Valenti WM
    AIDS Read; 2004 Oct; 14(10):541-3, 547-50. PubMed ID: 15510390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment: fixed-dose combination formulations are the answer, what was the question?
    Pavia AT
    AIDS Read; 2004 Oct; 14(10):549. PubMed ID: 15510391
    [No Abstract]   [Full Text] [Related]  

  • 3. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose combinations improve medication compliance: a meta-analysis.
    Bangalore S; Kamalakkannan G; Parkar S; Messerli FH
    Am J Med; 2007 Aug; 120(8):713-9. PubMed ID: 17679131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two drugs in one pill.
    Vazquez E
    Posit Aware; 1997; 8(6):19. PubMed ID: 11364854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy.
    Llibre JM; Arribas JR; Domingo P; Gatell JM; Lozano F; Santos JR; Rivero A; Moreno S; Clotet B;
    AIDS; 2011 Sep; 25(14):1683-90. PubMed ID: 21673556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs associated with combination antiretroviral therapy in HIV-infected patients.
    Yazdanpanah Y
    J Antimicrob Chemother; 2004 Apr; 53(4):558-61. PubMed ID: 14985277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment adherence improves outcomes and manages costs.
    Valenti WM
    AIDS Read; 2001 Feb; 11(2):77-80. PubMed ID: 11279875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Providing antiretroviral therapy for HIV infection.
    Steinbrook R
    N Engl J Med; 2001 Mar; 344(11):844-6. PubMed ID: 11248164
    [No Abstract]   [Full Text] [Related]  

  • 11. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Guide 2000: the antiretroviral agents.
    Gallant JE
    Posit Aware; 2000; 11(1):30-1. PubMed ID: 11366347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
    Mouala C; Kaba-Mebri J; Wata JB; Rey JL
    Sante; 2006; 16(2):119-30. PubMed ID: 17116636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly active antiretroviral therapy (HAART)--plus: next steps to enhance HAART in resource-limited areas?
    Flanigan TP; Wools-Kaloustain K; Harwell J; Cu-Uvin S; Kimaiyo S; Carter EJ
    Clin Infect Dis; 2007 Dec; 45(11):1499-501. PubMed ID: 17990234
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of treatment adherence in HIV.
    Schaecher KL
    Am J Manag Care; 2013 Sep; 19(12 Suppl):s231-7. PubMed ID: 24495293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal drug treatment regimens for HIV depend on adherence.
    Krakovska O; Wahl LM
    J Theor Biol; 2007 Jun; 246(3):499-509. PubMed ID: 17320115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of adherence to highly active antiretroviral therapy among HIV-1-infected patients in Côte d'Ivoire.
    Diabaté S; Alary M; Koffi CK
    AIDS; 2007 Aug; 21(13):1799-803. PubMed ID: 17690579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
    Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
    AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.